Published: August 26, 2010
Research and Markets: Gingivitis and Periodontitis Therapy Area Pipeline Report 2010 Provides Detail on the Top 20 Companies with Products in the Early Stage of Development
DUBLIN - (BUSINESS WIRE) - Research and Markets (http://www.researchandmarkets.com/research/c7021e/gingivitis_and_per)
has announced the addition of the "Gingivitis
and Periodontitis Therapy Area Pipeline Report" report to their
offering.
Life Science Analytics' Gingivitis
and Periodontitis Therapy Area Pipeline Report contains detailed
information on the gingivitis and periodontitis drug pipeline. This
report provides insight into the pipeline status of gingivitis and
periodontitis drugs by company and by stage as well as a summary of the
latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on
drug pipelines, by company and by stage, for each specific therapy area.
The latest news, by company, also ensures that each report is fresh and
up-to-date.
In addition to new developments and disease specific pipeline projects,
each report also contains extensive information in tabular format on a
company's full product pipeline and products by phase of development
with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed
product descriptions, information on partnering activity plus clinical
trial intelligence. Each Therapy Area Pipeline Report also provides
detail on the top 20 companies with products in the early stage of
development and the top 20 companies with products in the late stage of
development. Finally, each report also provides a comparison with other
major indications in the disease hub based on Marketed Products vs.
Pipeline Products.
Key benefits
-
Understand a company's strategic position by accessing detailed
independent intelligence on its product pipeline for specific therapy
areas.
-
Keep track of your competitors and partners by better understanding
their product pipeline.
-
Monitor a company's research effectiveness by determining pipeline
depth and number of products in development by clinical phase for
specific disease areas.
-
Maintain a critical competitive advantage.
Key Topics Covered:
-
Epidemiology Report
-
% of Products by Phase of Development
-
No. of Products by Phase of Development
-
Marketed Products vs. Pipeline Products
-
Company Overview - Pipeline Projects
-
Legend
-
--Top 5 Companies in Early Stage Gingivitis and Periodontitis Products
-
--Top 5 Companies in Late Stage Gingivitis and Periodontitis Products
-
--Top 5 Companies in Marketed Gingivitis and Periodontitis Products
-
Upcoming Milestones
-
Product Sales
-
Full Pipeline View
-
--Product Details : Unknown/Research
-
--Product Details : Pre Clinical
-
--Product Details : Phase I
-
--Product Details : Phase II
-
--Product Details : Phase III
-
--Product Details : Pending Approval
-
--Product Details : On the Market
-
News Updates
-
--Deals & Alliances
For more information visit http://www.researchandmarkets.com/research/c7021e/gingivitis_and_per.
Source: Life Science Analytics

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News